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While the insulin-like growth factor (IGF) system plays a fundamental role in regulating embryonic and placental growth,
the speci®c contributions of the six IGF binding proteins (IGFBPs 1±6) to these processes are not well understood. We
here focus on IGFBP expression in the extraembryonic environment, which both supports and constrains embryonic growth,
and have used in situ hybridization to determine sites of IGFBP mRNA synthesis in the pregnant rat uterus and placenta.
We ®nd that all IGFBPs are expressed in distinct, changing patterns in the uterine endometrium, at the decidual boundary,
in the decidual vasculature, and in the myometrium during pregnancy. Within the endometrium, the most prominent
change is that expression of IGFBP-1 begins in some, but not all, endometrial glands prior to implantation and then expands
to include all secretory epithelia shortly after implantation. During the period of rapid decidual proliferation that follows
implantation, IGFBP-3, -4, and -5 transcripts are all detected in a laminar array at the boundary between the decidua and
the nondecidualized endometrium. In the decidual vasculature at Day (d) 8.0, both IGFBP-3 and IGFBP-4 mRNAs are
detected in dilating blood vessels, with BP-3 most prominent in the antimesometrial plexus and BP-4 primarily at the
mesometrial pole. Later (d11.5), all decidual vessels express high levels of IGFBP-3 and lower levels of IGFBP-4 mRNAs.
Finally, changes in expression of several IGFBPs also occur within the myometrium during pregnancy. For example, IGFBP-
2 is expressed in the inner circular layer shortly after implantation, and expression increases through late gestation. In
contrast, IGFBP-5 hybridization occurs over both myometrial layers before implantation, but decreases in intensity and
spatial distribution as pregnancy proceeds. Finally, and most strikingly, IGFBP-6 expression, barely detectable in the d7.0
myometrium, gradually increases until it is very strongly transcribed during the placental stages. Taken together, these
observations suggest multiple roles for IGFBPs in supporting implantation, regulating the extent of decidualization, modu-
lating local levels of vascular IGFs, and regulating uterine muscular growth. q 1997 Academic Press
INTRODUCTION maturation of the myometrium is prevented and Graa®an
follicles are absent from the ovaries (Baker et al., 1996).
There are at least three known IGF receptors. The IGFsSeveral components of the mitogenic insulin-like growth
are thought to exert their activity primarily throughfactor (IGF) system are required for normal embryonic and
IGFR1, but they may also activate the insulin receptorplacental growth in rodents (Baker et al., 1993). Speci®cally,
(reviewed in LeRoith et al., 1995b). Genetic evidence sug-mice unable to produce IGF-II suffer both embryonic and
gests that IGF-II also acts through an additional unidenti-placental growth de®cits (DeChiara et al., 1990), while only
®ed receptor (IGFRX) in the placenta (Baker et al., 1993;the embryo is affected in the absence of IGF-I (Liu et al.,
Ludwig et al., 1996). Finally, the bifunctional type 2 IGF1993; Powell-Braxton et al., 1993) or the type 1 IGF receptor
receptor/mannose-6-phosphate receptor (M6PR/IGFR2)(IGFR1, see Liu et al., 1993). IGF-I is also essential for nor-
binds IGF-II, but not IGF-I (Morgan et al., 1987). Recentmal development of the reproductive systems of both sexes
gene targeting studies have shown that the major IGF-spe-(Baker et al., 1996). For example, in females lacking IGF-I,
ci®c function of IGFR2 is the clearance of IGF-II from the
extracellular environment (Lau et al., 1994; Wang et al.,
1994; Ludwig et al., 1996).1 To whom correspondence should be addressed. Fax: 908-235-
4990/5513. E-mail: pintar@mbcl.rutgers.edu. Complicating any physiological analysis of the IGF sys-
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of Laboratory Animal Resources Commission on Life Sciences,tem is a family of high-af®nity IGF binding proteins
1993). Uteri and placentas from timed-pregnant Sprague±Dawley(IGFBPs) present in most, if not all, body ¯uids (reviewed
rats, as well as uteri from late estrous rats, were dissected and ®xedin Jones and Clemmons, 1995) and expressed by a wide
in 4% paraformaldehyde/PBS, equilibrated in 20% sucrose/PBS,variety of cell types during embryonic development (Wood
embedded in O.C.T. (Miles, Inc., Elkhart, IN), sectioned as de-et al., 1990, 1992; Pintar et al., 1991; Streck et al., 1992;
scribed previously (Hock®eld et al., 1993), and mounted on slides
Cerro et al., 1993; Schuller et al., 1993; Green et al., 1994). coated with TESPA (Pierce Chemical Company, Rockford, IL). Con-
IGFBPs bind the IGFs with af®nities comparable to, and ceptuses were staged precisely by examining embryonic limb mor-
often greater than, the af®nities of IGF receptors for IGFs phology based on the method of Wanek et al. (1989). Two uteri at
(Gammeltoft et al., 1985; Kiefer et al., 1993). Further, they Day (d) 3.5 pc and a minimum of eight concepti from two or more
account for the majority of cell-surface IGF binding sites in litters each at ages d7.0, d8.0, and d10.0 were used for this study.
®broblasts (McCusker et al., 1990). Ascribing speci®c in Two uteroplacentas each from two different litters at each stage
were used for the d11.5, d14.5, and d18.5 experiments. For compari-vivo functions to the IGFBPs has been dif®cult since, de-
son, C57BL/6J mouse concepti at d14.0 and d18.0 were also exam-pending on the experimental paradigm in vitro, IGFBPs can
ined. 35S-labeled antisense cRNAs for the IGFBPs, IGFs, and IGFR1inhibit or enhance IGF activity and can also act indepen-
were transcribed from plasmids pRBP1-501 (Murphy et al., 1990),dently of the IGFs (for detailed review, see Jones and Clem-
pG3-2-11 (Brown et al., 1989), pRBP3-AR (Shimasaki et al., 1989),mons, 1995). It is clear, however, that IGFBPs can exert
pRBP4-SH (Shimasaki et al., 1990), pGEM3Z/mBP5,2-3 (James et
tissue-speci®c effects during development, since recent ge- al., 1993), pRBP6-PP (Shimasaki et al., 1991), pRIGF1-ES (Roberts
netic experiments have revealed that IGFBP-2 is required et al., 1987), pRIGF-II-BP (Whit®eld et al., 1984), and pRIGFR1-ER
for normal growth of the spleen (Pintar et al., 1996). (Werner et al., 1989). pRBP1-501 contains a PCR fragment (nucleo-
The IGF system has been implicated in several events tides 486 ±892) of a rat IGFBP-1 cDNA clone. pG3-2-11 contains a
which are necessary to support embryonic growth and devel- HindIII±SacI fragment (nucleotides 502±1087) of a rat IGFBP-2
opment, such as the rapid growth of the uterus during preg- cDNA clone. pRBP3-AR contains an ApaI±RsaI fragment (nucleo-
tides 163±861) of a rat IGFBP-3 cDNA clone. pRBP4-SH containsnancy and the differentiation of the decidua from the endome-
a SmaI±HindIII fragment (nucleotides 435±878) of a rat IGFBP-4trial stroma (reviewed in Simmen et al., 1995). Also, since
cDNA clone. pGEM3Z/mBP5,2-3 contains nucleotides 512±988 ofmaternal, as well as fetal, IGF-I levels in¯uence the growth
a mouse IGFBP-5 cDNA clone. pRBP6-PP contains a PstI fragmentof the conceptus (Gluckman et al., 1992), uterine IGFBPs
(nucleotides 229±475) of a rat IGFBP-6 cDNA clone. pRIGF1-ESmay likewise be important regulators of embryonic growth.
contains a 320-base EcoRI/Sau3A fragment of a rat IGF-I cDNASeveral groups have reported changes in maternal serum
clone. pRIGF-II-BP contains a 551-base BamHI±PstI fragment of aIGFBP pro®les during pregnancy in a variety of species (Dav-
rat IGF-II cDNA clone. pRIGFR1-ER contains a 265-base EcoRI±
enport et al., 1990; Fielder et al., 1990; Gargosky et al., 1990; SmaI fragment of a type 1 IGF receptor rat cDNA clone. Transcrip-
Giudice et al., 1990, 1993; Wang et al., 1991; Baxter and tions were performed using SP6, T7, or T3 RNA polymerases (Pro-
Saunders, 1992; Lee et al., 1993; Chard et al., 1994; Markoff mega, Woods Hollow, WI, and Boehringer-Mannheim, Indianapolis,
et al., 1995; Nason et al., 1996). Likewise, uterine and ovarian IN) in the presence of ATP, CTP, GTP, and [35S]UTP. The resulting
IGFBP transcription varies during the estrous cycle (Geisert cRNA transcripts were puri®ed on Sephadex G-50 columns (Boeh-
ringer-Mannheim) and used without hydrolysis.et al., 1991; Nakatani et al., 1991; Erickson et al., 1992a,b;
In situ hybridizations were performed as previously describedSimmen et al., 1992; Ghahary et al., 1993; Girvigian et al.,
(Hock®eld et al., 1993). In short, tissue sections were mounted on1994), so it is reasonable to expect that changes in uterine
slides, brie¯y post®xed in 4% paraformaldehyde/PBS, dehydratedIGFBP expression could also occur during pregnancy. To date,
in ethanol series, acetylated with 0.05 M triethanolamine/0.25%little information about the cellular location of IGFBP expres-
acetic anhydride (v/v) (Sigma, St. Louis, MO), washed in 0.21 SSC,sion in the pregnant uterus has been available. IGFBP-1, a
redehydrated in ethanol series, prehybridization treated at roommajor endometrial protein in primates (Bell et al., 1985; Faz-
temperature, and then hybridized overnight at 507C, with probe
leabas et al., 1989) and cellular marker of decidualization in concentrations of 2 1 104 cpm/ml. Sections were washed in 50%
humans (Rutanen et al., 1991) is expressed by rat uterine formamide/10 mM DTT/11 SSC, treated with 100 mg/ml RNaseA
luminal epithelial (ULE) cells during early decidual stages (Boehringer-Mannheim), washed in 0.51 SSC, dehydrated, and sub-
(Sadek et al., 1994). IGFBP-4, generally considered to be an jected to X-ray ®lm or liquid nuclear track emulsion autoradiogra-
IGF inhibitor (Jones and Clemmons, 1995), is localized to the phy (1-, 2-, or 4-week exposures) and hematoxylin/eosin counter-
endometrial stroma (Markoff et al., 1995; Pintar et al., 1996), staining. Hybridization with control (sense) RNA yielded very low
backgrounds. The distinct hybridization patterns observed in theseand later, IGFBP-2 mRNA is prominently expressed by cyto-
experiments further demonstrate probe speci®city. In all experi-trophoblasts during placentation (Zhou and Bondy, 1992). To
ments, specimens from several stages were hybridized concur-address potential effects of IGFBPs on IGF action during preg-
rently, indicating that changes in hybridization pattern and inten-nancy, we here use in situ hybridization to elucidate the ex-
sity re¯ect changes in mRNA expression and not artifactual varia-pression of all six IGFBP mRNAs in the uterus and placenta
tion between experiments.through the preimplantation, embryonic, and fetal periods.
Microscopic visualization of sections was accomplished using
either dark-®eld illumination at low magni®cation or concurrentMATERIALS AND METHODS
bright-®eld and epipolarization illumination at high magni®ca-
tion. Images were recorded by photomicrography or computer-All studies were conducted in accordance with NIH guidelines
(Committee on Care and Use of Laboratory Animals of the Institute assisted video microscopy. Video images were digitized by a Sony
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FIG. 1. IGFBP mRNAs are present in the preimplantation uterus. All panels are high-power epipolarization/bright-®eld (EP/BF) photomicro-
graphs of d3.5 pc uteri, except B and E, which are EP/BF video micrographs of the same material. (A) IGFBP-1 is expressed by some (white
arrows), but not all (black arrows), endometrial glands and is absent from the luminal epithelium (arrowheads); 1001, original magni®cation.
(B) With long exposure times (e.g., 4 weeks), IGFBP-2 hybridization is detectable over discrete basophilic endometrial cells (arrows) near the
circular muscle layer of the myometrium (cm); original magni®cation, 4001. (C) IGFBP-3 hybridization (blue-green grains) over endometrial
stromal cells. Arrows point to IGFBP-3-positive endothelial cells; original magni®cation, 2001. (D) Periluminal transcription of
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FIG. 2. IGFBP transcription by the secretory components of the postimplantation uterus. (A) High-power EP/BF photomicrograph shows
IGFBP-1 hybridization (d7.0 pc) over columnar epithelial cells of uterine lumen (ul) and all endometrial glands (arrows); original magni®cation,
1001. (B) Adjacent section showing absence of IGFBP-2 hybridization in luminal and glandular environments. Glands in B are contiguous
with those in A (arrows); 1001, original magni®cation. (C) As the decidua grows, luminal epithelial cells surrounding the decidua become
squamous in appearance. High levels of IGFBP-1 hybridization are detected in columnar (co) and pseudostrati®ed (ps) luminal epithelial cells
surrounding the nondecidualized endometrium, with lower levels in the cuboidal (cu) and squamous (s) epithelia near the decidua (d10.0);
original magni®cation, 2001. (D) IGFBP-3 mRNA is expressed in the luminal (ule), but not glandular, epithelium, as well as in some periluminal
stromal cells at d7.0 (arrows); original magni®cation, 4001. (E) IGFBP-5 is expressed by periluminal stroma at d7.0; original magni®cation,
4001. Abbreviations: co, columnar epithelium; cu, cuboidal epithelium; dec, decidua; eg, endometrial gland; en, nondecidualized endometrium;
ps, pseudostrati®ed epithelium; s, squamous epithelium; ul, uterine lumen; ule, uterine luminal epithelium.
DXC-151A CCD color video camera (Sony Corp., Mahwah, NJ) puter, Cupertino, CA), NIH Image (public domain software by
Wayne Rasband, U.S. National Institutes of Health, http://rsb.connected to a PowerMacintosh 7100/80 AV computer (Apple
Computer, Cupertino, CA). Software used for digitization and info.nih.gov/nih-image/), and Adobe Photoshop (Adobe Corp.,
Mountain View, CA).subsequent analysis included Apple Video Player (Apple Com-
IGFBP-5 in the stroma. (E) IGFBP-6 mRNA is detected over connective tissue in the stratum vascularis (sv) of the myometrium after long
exposure times; original magni®cation, 4001. (F) IGFR1 mRNA is widely expressed within the myometrium (particularly the circular layer)
and the endometrium. Note also hybridization over an endometrial capillary (arrow); original magni®cation, 2001. Abbreviations: bv, blood
vessel; cm, circular muscle; lm, longitudinal muscle; m, myometrium; sv, stratum vascularis; ul, uterine lumen.
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FIG. 3. Peridecidual IGFBP transcription on Gestational Day (gd) 7.0. (A) Low-power (801, original magni®cation) dark-®eld (DF) photomi-
crograph of a d7.0 pc uterus showing IGFBP-3 hybridization over nondecidualized endometrial stromal cells (nd), particularly in periluminal
area (large arrow). (B) Low-power DF photomicrograph of a nearby section hybridized with IGFBP-4 probe. Note diffuse pattern of expression
over both decidualized (dec) and nondecidualized stroma; original magni®cation, 801. (C) Narrow band of IGFBP-5 hybridization sur-
rounding the decidua. Section is slightly oblique, and expression is highest at antimesometrial pole (am). Also note positive signal in both
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cellular and transcriptional levels a report of increasedRESULTS
IGFBP peptide levels in whole endometrial extracts at corre-
The IGF binding proteins are present in the uterine envi- sponding stages in pregnant mice (Markoff et al., 1995).
ronment throughout gestation. Changes in their expression Taken together, these results suggest that IGFBPs can exert
patterns are associated with important events in pregnancy their activity at or close to their sites of synthesis. As early
such as embryonic implantation, decidual growth, vascular as 7 days pc the epithelial cells lining the uterine lumen
remodeling of the endometrium, and preparation of the and all endometrial glands strongly express IGFBP-1 mRNA
myometrium for parturition. (Fig. 2A). These two epithelial populations comprise the
major secretory components of the rodent uterus. Interest-
IGFBPs in the Preimplantation Uterus ingly, although IGFBP-2 is prominently expressed by the
rat ULE during proestrus and estrus (Girvigian et al., 1994),As a positive control for this study, we con®rmed the
it is completely undetectable in these cells during preg-observations of Girvigian et al. (1994) in the cycling rat
nancy (Fig. 2B). As decidualization proceeds (e.g., d10.0),uterus by detecting late estrous transcription of IGFBP-2 at
ULE IGFBP-1 mRNA levels remain high in the tall colum-low levels in the ULE, IGFBP-3 in the periluminal stroma,
nar and pseudostrati®ed epithelium of the interembryonicand IGFBP-5 in both layers of the myometrium (data not
regions, but hybridization is less intense, and is sometimesshown). In addition, we detect several IGFBP mRNAs in
almost undetectable, in the cuboidal and particularly thepreimplantation uteri (d3.5 pc). Surprisingly (see Discus-
squamous epithelia surrounding the decidua (Fig. 2C). Ex-sion), IGFBP-1 hybridization is detected in the endometrial
pression of IGFBP-1 (and IGFBP-5, see below) may accountglands farthest from the uterine lumen, but is generally
for some of the unidenti®ed bands visible in ligand blottingabsent from the luminal epithelium and from glands near
experiments reported by Markoff et al. (1995). Low levelsthe lumen (Fig. 1A). At d3.5, IGFBP-3 mRNA is limited to
of IGFBP-4 transcription are also detected in some, but nota few scattered periluminal stromal cells, some of which
all, endometrial glands (not shown), while in contrast,are endothelia (Fig. 1C). Markoff et al. (1995) reported ex-
IGFBP-3 hybridization occurs in the ULE but not the glandspression of IGFBP-4 by mouse periluminal stromal cells at
(Fig. 2D).d4, and we see similar hybridization in the d3.5 rat (not
shown). In addition, we observe IGFBP-5 mRNA throughout After implantation, several IGFBPs, including IGFBPs -3
the periluminal stroma, and also in both layers of the myo- (Fig. 2D), -4, and -5 (Fig. 2E) are also expressed by nondecidu-
metrium (Fig. 1D). alized stromal cells adjacent to the luminal epithelium.
With comparatively long exposure times (e.g., 4 weeks), IGFBP-3 is particularly strongly expressed by periluminal
we also detect weak IGFBP-1 hybridization over a sparse stromal cells near the decidua (see heavy arrow, Fig. 3A).
number of stromal cells (not shown). Similarly, IGFBP-2 The outer margin of the rat decidua is a thin, collagen-
hybridization becomes detectable over small, scattered ba- rich capsule of ¯attened, elongated ®broblasts termed the
sophilic endometrial cells near the myometrium (Fig. 1B) ®brous zone (Bridgman, 1948a). A laminar pattern of IGFBP
and IGFBP-6 mRNA is observed in connective tissue of the mRNA expression is detected in cells on both sides of this
myometrial stratum vascularis (Fig. 1E). Con®rming the margin, particularly surrounding the antimesometrial as-
work of Kapur et al. (1992), we detect IGF-I transcription pect of the rapidly proliferating secondary decidual zone
in d3.5 glandular and luminal epithelial cells, as well as (see Figs. 3 and 4). An intense ring of IGFBP-3 hybridization
stromal cells (not shown). Likewise, we extend the work of is seen over nondecidualized stromal cells surrounding the
Zhou and Bondy (1992) to an earlier stage, detecting IGFR1 antimesometrial decidua beginning at d7.0 (Figs. 3A and
mRNA (Fig. 1F) over cells in both the endometrium and 3D) and extending mesometrially by d11.5 (see Fig. 4C).
myometrium. IGFR1 hybridization is greatest over endome- This ring of IGFBP-3 is continuous with the hybridization
trial capillaries and the inner circular layer of the myome- over periluminal cells mentioned earlier, suggesting that
trium. IGFBP-3 may be buffering IGF communication between the
lumen and the decidua. Likewise, a similar, albeit less ex-
Uterine IGFBPs during Decidualization tensive, ring of stromal IGFBP-5 expression is detectable
from d7.0 (Fig. 3C) through d14.5 (Fig. 5F). IGFBP-4 mRNAWe ®nd a signi®cant increase in the mRNA expression
of several IGFBPs following implantation, extending to the expression occurs in a band straddling and including the
layers of the myometrium (cm, circular layer; lm, longitudinal layer); original magni®cation, 801. (D) High-power EP/BF photomicrograph
from same section as in A. Note the presence of endometrial glands, which are characteristic of nondecidualized tissue, within IGFBP-3-
positive stroma; original magni®cation, 2001. (E) Expression of IGFBP-3 mRNA by discrete cells within the antimesometrial decidua.
Arrows point to endothelia; original magni®cation, 4001. (F) High-power videomicrograph of area boxed in B. Diffuse IGFBP-4 hybridization
is detected over cells on both sides of the decidual margin, particularly in the ®brous zone (fz). Note the absence of grains over an
endometrial gland (eg); original magni®cation, 2001. Abbreviations: am, antimesometrial pole; cm, circular myometrium; dec, decidua;
eg, endometrial gland; fz, ®brous zone; lm, longitudinal myometrium; nd, nondecidualized endometrium.
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FIG. 4. IGFBPs in the decidual vasculature. A, C, E, and G are low-power DF photomicrographs at 801, original magni®cation (A, E) or
601 (C, G). B, D, F, and H-L are high-power EP/BF photo or video micrographs at 2001 magni®cation, except F, which is at 4001. (A and
B) IGFBP-3 mRNA is expressed in capillary endothelial cells surrounding the d8.0 pc primary decidual zone. (C and D) IGFBP-3 transcripts
are detected over all endothelial cells in dilated maternal blood sinuses at d11.5 pc. Note also the peridecidual IGFBP-3 hybridization
(arrowheads), weaker signal in uterine spiral artery (large arrow), and expression in embryonic myotomes (e). (E) IGFBP-4 hybridization at
d8.0 over early decidual blood vessels in the mesometrial pole. (F) Strong IGFBP-4 mRNA hybridization is detected over early decidual
capillaries (d7.5). (G and H) The IGFBP-4 mRNA pattern is similar to, but weaker than, the pattern of IGFBP-3 expression shown in C
and D. Note strong hybridization over the embryonic mesoderm (em) and yolk sac (arrow). (I) Trophoblast giant cells (arrows) are frequently
seen adjacent to IGFBP-3-positive decidual endothelia at d11.5. Occasional giant cells are seen within the maternal sinusoids (see arrowed
cell, lower left corner). (J) IGFBP-2 is strongly expressed by cytotrophoblasts (cy) in the region of the uterine central artery (d11.5). (K)
Hybridization of IGFBP-3 over endothelial cells associated with the central artery, allantoic vessels (av, arrowhead), and decidua. (L) IGFBP-
4 hybridization is limited to decidual vessels near the central artery (arrows). Abbreviations: am, antimesometrial pole; av, allantoic blood
vessel; ca, chorioallantoic plate; cy, cytotrophoblasts; dec, decidua; e, embryo; em, embryonic mesoderm; mp, mesometrial pole; ms,
maternal sinusoid; pdz, primary decidual zone; sdz, secondary decidual zone.
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®brous zone, encompassing both decidualized and nonde- Several IGFBP mRNAs are detected in uterine muscles dur-
ing decidualization. At 8.0 days pc expression of IGFBP-2cidualized cells (Figs. 3B and 3F). This band of IGFBP-4 tran-
scription gradually diminishes until the placental stages, mRNA is detectable in the inner aspect of the circular layer
(Fig. 5A). IGFBP-5, present in the myometrium at pre-im-when it is undetectable (e.g., d14.5). In addition to the ring-
like expression surrounding the decidua, individual stromal plantation stages, continues to be expressed by both the
outer longitudinal and the inner circular muscle layers wellcells and capillaries deep within the antimesometrial cap-
sule express IGFBP-3 mRNA at d7.0 (Fig. 3E). after implantation (Fig. 5B). As decidualization proceeds,
myometrial IGFBP-2 mRNA slowly increases in the circularAs pregnancy proceeds, the decidua continues to grow
and the uterine vasculature within this region is remodeled, layer (Fig. 5C), while IGFBP-5 transcription gradually de-
creases in the longitudinal layer until it is almost absent atlargely through endothelial hypertrophy and vessel dilation
(Welsh and Enders, 1991). IGFBP-3 hybridization is abun- d11.5 (Fig. 5D). IGFBP-6 hybridization is barely, if at all,
detectable at d7.0 (Fig. 6A), although signi®cant IGFBP-6dant at d8.0 in the lateral antimesometrial capillary plexus,
which surrounds the thin, periembryonic primary decidual signal is observed in both myometrial layers by d11.5 pc
(Fig. 6B).zone (Figs. 4A and 4B). In contrast, we detect IGFBP-4
mRNA in blood vessel endothelia throughout the decidua,
particularly in the glycogenic mesometrial aspect (Figs. 4E IGFBPs in the Mid- to Late-Gestation Uterus andand 4F). During this stage of vascularization we detect con-
Placentasiderable IGFBP-4 hybridization in both decidual capillaries
and uterine arteries. After the decidual capillary meshwork Decidualization is essentially complete and placental
structures are well differentiated by d11±12 pc in the ratis laid down, maternal blood vessels close to the implanta-
tion site begin to dilate (Krehbiel, 1937; Welsh and Enders, (Everett, 1935; Krehbiel, 1937; Bridgman, 1948a,b). By this
point, rapid growth of the embryo, the decidua, and the1991). This process gradually extends throughout the de-
cidua until d11, when nearly all decidual vessels are sinusoi- extraembryonic cavities has displaced the bulk of the non-
decidualized glandular endometrium to the portions of thedal. These sinusoids are the precursors of placental-stage
lacunae through which maternal blood will ¯ow. As dila- uterus between conceptuses. IGFBP-1 continues to be ex-
pressed by the epithelium of the uterine lumen throughouttion proceeds, endothelial IGFBP-3 mRNA increases, and
IGFBP-4 mRNA decreases. By d11.5 very strong IGFBP-3 pregnancy (e.g., d18.5, Fig. 7A), although epithelial IGFBP-
3 transcripts are no longer detectable (Fig. 7B). However,hybridization is detected over cells lining the sinusoids
throughout the decidua (Figs. 4C and 4D), while lower levels the periluminal stroma continues to express IGFBP-3 (Fig.
7B), IGFBP-4, and IGFBP-5 mRNAs through late gestation.of IGFBP-4 remain detectable in a similar pattern (Figs. 4G
and 4H). In addition, periluminal IGFBP-6 transcription is detected
by d18.5 (Fig. 7C).Trophoblast giant cells are frequently observed adjacent
to IGFBP-3-positive maternal endothelia (Fig. 4I). These gi- There is little change in decidual IGFBP expression during
the placental stages, save for the near disappearance ofant cells are in the process of penetrating maternal vessels
(Fig. 4I), as well as phagocytosing dead or dying decidual IGFBP-4 hybridization from decidual sinusoids (d18.5, not
shown). In contrast, IGFBP-3 transcripts continue to be de-cells (for review, see Hoffman and Wooding, 1993). Within
the large uterine arteries, we detect IGFBP-3 and -4 mRNAs tected over the squamous linings of maternal lacunñ. Late
in gestation, all that remains of the nondecidualized endo-over endothelial cells, with IGFBP-3 also in the tunica ad-
ventitia at d11.5 (see also Zhou and Bondy, 1992). Interest- metrium is a narrow strip of tissue beneath the decidua
and in the regions between concepti. These nondecidualizedingly, IGFBP-2 hybridization is prominent over the glyco-
genic cytotrophoblasts which begin to accumulate at the stromal cells at the placental periphery continue to express
substantial levels of IGFBP-3 mRNA and, to a lesser degree,con¯uence of the uterine central artery and the chorioallan-
toic vasculature at d11.5 (Fig. 4J). It is noteworthy that mice IGFBP-5 mRNA at d18.5.
Myometrial growth continues into the placental period.unable to produce IGF-II have much diminished placentas
when compared to normal mice and that the difference in By late gestation the uterus has developed considerable
muscle mass, and changes in IGFBP expression indicate asize is attributed to much lower numbers of glycogen-pro-
ducing cells in the mutant placentas (Lopez et al., 1996). possible role for the IGF system in myometrial anabolism.
Relatively few myometrial cells are positive for IGFBP-2IGFBP-3 mRNA is also detected in this region (Fig. 4K),
although it is not clear whether the cells in question are of hybridization at d11.5 (Fig. 5C), but by d14.5 substantial
levels of IGFBP-2 mRNA are detected in the circular layermaternal arterial or allantoic endothelial origin. In contrast,
little or no IGFBP-4 hybridization is detected in the arterial (Fig. 5E), and this continues through late gestation (Fig. 5G).
In contrast, IGFBP-5 transcription at d14.5 is less extensiveregion, except over decidual sinusoids (Fig. 4L).
Like the endometrium, the myometrium undergoes a pro- than that in decidual stages (Fig. 5F) and by d18.5 is limited
to the connective tissue surrounding the longitudinal layergram of growth during pregnancy (Reynolds, 1965), and
IGFBPs have been associated with muscle growth and differ- (Fig. 5H). Throughout pregnancy myometrial IGFBP-6 sig-
nals increase until d14.5, when very intense hybridizationentiation in vitro (Ernst et al., 1992; James et al., 1993; Bach
et al., 1994; Ewton and Florini, 1995; Silverman et al., 1995). is detected in both muscle layers (Fig. 6C). This pattern
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FIG. 6. IGFBP-6 is upregulated in uterine muscle during pregnancy. (A±D) Low-power dark-®eld photomicrographs. (A) Relatively little
IGFBP-6 mRNA is detected at d7.0 pc; 1201 (all magni®cations are given at original sizes). (B) Both myometrial layers express IGFBP-6
at e11.5; 1001. IGFBP-6 is expressed at very high levels in the myometrium and endometrial stroma at d14.5 (C; 601) and d18.5 (D; 601).
(E) Bright-®eld videomicrograph showing accumulation of IGFBP-6 mRNA over and around myometrial nuclei; 1001. Abbreviations: cm,
circular muscle; dec, decidua; ca, chorionic plate/early placenta; e, embryo; es, endometrial stroma; lm, longitudinal layer; lz, labyrinthine
zone of placenta; jz, junctional zone of placenta; mg, area of metrial gland.
FIG. 5. Myometrial expression of IGFBP-2 and -5 mRNAs from gd 8.0 to gd 18.5. (A) Low-power DF photomicrograph of IGFBP-2
hybridization over cells of the d8.0 pc inner circular muscle layer; original magni®cation, 1001. (B) Low-power DF photomicrograph of
d7.0 pc uterus showing IGFBP-5 transcripts in both layers of the myometrium (arrow points to longitudinal layer); original magni®cation,
1001. (C) High-power (2001) EP/BF image of IGFBP-2 expression in inner layer of the d11.5 pc myometrium. (D) 2001 EP/BF image of
IGFBP-5 transcription in d11.5 pc uterine circular muscle layer and periluminal stroma (es). (E) High levels of IGFBP-2 mRNA expression
in d14.5 circular myometrium (cm). No hybridization is detected in the adjacent periluminal stroma. Notice moderate IGFBP-2 expression
in the labyrinthine placenta (lz) and extremely strong signal in junctional zone cytotrophoblasts (jz); original magni®cation, 801. (F)
IGFBP-5 transcription is nearly absent in the d14.5 circular muscle layer (cm, compare with D). Note hybridization in nondecidualized
endometrial stroma (arrow) and connective tissue surrounding the longitudinal muscles; original magni®cation, 801. (G) Circular muscle
IGFBP-2 mRNA expression continues at e18.5; original magni®cation, 601. (H) Myometrial IGFBP-5 hybridization is limited to super®cial
connective tissue layers of the longitudinal muscle at d18.5 pc (EP/BF); original magni®cation, 601. (I) Near absence of IGFBP-2 hybridiza-
tion in mouse junctional zone cytotrophoblasts (d18.0); original magni®cation, 601. Note similarity of circular muscle signal to that of
the rat (E). Abbreviations: cm, circular muscle; dec, decidua; es, endometrial stroma; jz, junctional zone of placenta; lm, longitudinal
muscle; lz, longitudinal zone of placenta; mg, region of granulated metrial gland; ul, uterine lumen.
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FIG. 7. Periluminal IGFBP expression during placental stages. (A) High-power EP/BF photomicrograph of IGFBP-1 hybridization in uterine
luminal epithelial (ule) cells at d18.5 pc; 2001magni®cation (all magni®cations given as original sizes). (B) Similar section showing IGFBP-
3 transcript in periluminal endometrial stroma (es); 2001. (C) Bright-®eld video micrograph of IGFBP-6 mRNA in d18.5 stroma; 2001.
Abbreviations: cm, circular muscle; es, endometrial stroma; ul, uterine lumen; ule, uterine luminal epithelial cells.
continues through d18.5 (Fig. 6D). IGFBP-6 hybridization is throughout pregnancy (Everett, 1935) and is the initial site
of hematopoeisis within the conceptus (Moore and Metcalf,concentrated over and around myometrial nuclei during
late gestation, consistent with Lobel et al.'s report (1965) 1970). Con®rming and extending the observation of Zhou
and Bondy (1992) that IGFBP-1 (Fig. 8A) is expressed by theof perinuclear accumulation of cytoplasmic RNAs in hyper-
trophic myometrial cells. yolk sac epithelium (YSE) throughout gestation and that
IGFBP-4 (Fig. 8C) is expressed by the YSE during mid-gesta-The placenta of the rat and mouse consists of splanchno-
pleure-derived blood vessels through which fetal blood tion (d11.5±d14.5), we in addition detect epithelial IGFBP-
2 hybridization at d11.5 (Fig. 8B). YSE hybridization of¯ows (Davies and Glasser, 1968), surrounded by two layers
of syncytiotrophoblasts and a fenestrated cytotrophoblast IGFBP-2 declines after d14.5 pc and is not detectable at
d18.5 (not shown), similar to the decline in epithelialepithelium (Jollie, 1964; Enders, 1965; Kirby and Bradbury,
1965). These complexes, analogous to primate chorionic IGFBP-4 expression reported by Zhou and Bondy (1992).
These changes in binding protein expression coincide with,villi, form a labyrinthine zone which is bathed in maternal
blood. Beneath the labyrinthine zone and adjacent to the and may be related to, increases in the transport of macro-
molecules (e.g., maternal antibodies, Padykula et al., 1966)decidua is the junctional zone, which marks the deepest
widespread penetration of the trophoblast into maternal tis- and glycogen storage (Bridgman, 1948a) by the visceral yolk
sac epithelium. Interestingly, these physiological changessue and which is also bathed by maternal blood (Davies and
Glasser, 1968). In agreement with Zhou and Bondy (1992), occur as the parietal endoderm degenerates (Padykula et
al., 1966), exposing the visceral YSE to the contents of thewe detect moderately high levels of IGFBP-2 hybridization
in labyrinthine trophoblast epithelia and very high levels uterine lumen, which may include maternal IGF-I and
IGFBPs. Meanwhile, the yolk sac vasculature continues toover junctional zone cytotrophoblasts in mid- to late-gesta-
tion rat placentas (Figs. 5E and 5G). Surprisingly, only very express both IGFBP-3 and IGFBP-4 mRNAs throughout the
placental stages (d14.0±18.0) in the mouse (Figs. 8D and 8E,weak hybridization of IGFBP-2 probe was detectable over
cytotrophoblasts in the mouse placenta (Fig. 5I). In our prep- respectively) and the rat (Zhou and Bondy, 1992). IGFBP-1
and IGFBP-4 mRNAs are also expressed by cells of the amni-arations, the myometrium was included on placental sec-
tions, and comparable levels of myometrial IGFBP-2 mRNA otic membrane at d14.5 and d18.5 pc (not shown).
were detected in both rat and mouse (Figs. 5G and 5I), ar-
guing that the diminished hybridization in cytotrophoblasts DISCUSSION
represents a true difference in tissue-speci®c gene expres-
sion between these closely related species. The pregnant rodent uterus is a remarkably plastic system
which undergoes a program of rapid growth and differentiationThe yolk sac performs critical placental functions
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FIG. 8. Expression of IGFBPs in the yolk sac membranes. EP/BF photomicrographs showing (A) IGFBP-1 transcription in the rat yolk
sac epithelium at d11.5 pc, (B) IGFBP-2 hybridization in the yolk sac epithelium at d11.5, and (C) IGFBP-4 signal in the yolk sac epithelium
at d11.5. (D) IGFBP-3 and (E) IGFBP-4 expression in the d18.0 mouse yolk sac blood vessel endothelia. A, B, and C are at 2001 original
magni®cation; D and E are at 4001 original magni®cation. Abbreviations: bi, blood island; bv, blood vessel; gc, trophoblast giant cell;
ysc, yolk sac cavity.
in order to support an embryo and then rapidly resets itself scription described here correlate well with IGFBP peptide
pro®les from homogenized pregnant mouse endometria exam-after parturition. Previous studies have implicated the IGF
system in this process (for review, see Simmen et al., 1995), ined by Markoff et al. (1995). It is therefore likely that IGFBP
peptides function in an autocrine or paracrine manner, i.e.,but the speci®c roles of IGF binding proteins remain elusive.
To address this issue we have examined uteroplacental IGFBP close to their sites of synthesis. Taken together, these patterns
suggest that the IGFBPs play roles in processes as diverse asmRNA expression patterns throughout pregnancy, and we
®nd that all IGFBPs are present in this environment, with supporting implantation, limiting decidualization, modulat-
ing local levels of vascular IGFs, and regulating uterine muscu-unique temporal and spatial relationships. Previous work has
elucidated the cellular pattern of IGFBP mRNA expression in lar growth.
the cycling, nonpregnant rat uterus (Girvigian et al., 1994).
ImplantationWhile there are some similarities in IGFBP expression be-
tween diestrous and pregnant preimplantation uteri, there are Early conceptuses enter the uterine environment
shortly after fertilization, and this environment is rich inalso signi®cant differences. The cellular sites of IGFBP tran-
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secretory products derived from the luminal epithilium dramatic difference from the cycling ULE, which tran-
scribes copious amounts of IGFBP-2, particularly duringand the contiguous endometrial glands. At least one of
these products, leukemia inhibitory factor, is required for proestrus (Girvigian et al., 1994). Interestingly, IGFBP-2
strongly inhibits the migration-promoting activity ofnormal implantation in mice (Stewart et al., 1992). It is
with interest, then, that we note the strong expression both IGFs on smooth muscle cells in vitro (Gockerman
et al., 1995). Blastocysts must migrate over and betweenof IGFBP-1 transcription in preimplantation endometrial
glands at d3.5 pc, followed by expression in all secretory ULE cells in order to implant succesfully; thus, loss of
IGFBP-2 expression followed by the onset IGFBP-1 expres-epithelia by d7.0. This ®nding extends both to the tran-
scriptional level and to an earlier stage, the work of Sadek sion in the ULE may be a critical step in implantation at
the biochemical level.et al. (1994), which demonstrated the presence of IGFBP-
1 peptide in some, but not all, endometrial glands at d5.0 After penetrating the ULE, trophoblast cells are con-
fronted with the endometrial stroma, where a compli-and nearly all glands and the ULE at d7.0. Since IGFBP-1
peptide was not detectable at d3.0, it is likely that tran- cated scheme of IGF buffering appears to be in place.
IGFBP-5, which has been shown to enhance IGF activityscription at d3.5 represents the onset of IGFBP-1 gene
expression. Further, IGFBP-1 has been proposed to act pri- when bound to cell surfaces (Jones et al., 1993b), is promi-
nently expressed by the periluminal stroma, particularlymarily as an autocrine/paracrine factor in the uterus (Sa-
dek et al., 1994), and colocalization of transcript and pep- prior to implantation. Periluminal expression of IGFBP-
5, coupled with IGF-I expression by the adjacent ULE (Ka-tide supports this notion.
Our results validate the detection of epithelial IGFBP- pur et al., 1992), may provide a favorable environment for
blastocyst growth.1 transcription in arti®cially induced deciduomata (Croze
et al., 1990). Croze et al.'s observation (1990) coupled Recent work has indicated that IGFBP-3 may act pri-
marily as an inhibitor of mitogenesis (Valentinis et al.,with the well-characterized expression of IGFBP-1 by pri-
mate decidual cells in vivo (Bell et al., 1985; Fazleabas et 1995), and IGFBP-4 is generally a very potent inhibitor
of IGF action (Jones and Clemmons, 1995). Periluminalal., 1989; Rutanen et al., 1991) has led to the conclusion
that IGFBP-1 is intimately related to decidualization and hybridization to these mRNAs is most prominent over
stromal cells in the regions between implantation sitesmay even be a molecular marker for this event (Rutanen
et al., 1991). However, decidualization is a directional and is very low or absent in the decidual zones. This is
consistent with a role for these binding proteins havingprocess beginning at the luminal surface of the uterus and
progressing toward the myometrium (Krehbiel, 1937). At a negative effect on implantation, perhaps regulating the
number of succesful implantations in a pregnancy.d3.5, the IGFBP-1-positive glands are generally those far-
thest from the lumen, suggesting instead that IGFBP-1 is
associated with predecidual transformation of the uterus Decidualizationand, at least in the rodent, may be more properly regarded
as a more generalized pregnancy-associated peptide than The balance between IGF-induced proliferation or inva-
sion and the activity of IGF inhibitors may be critical inas a decidual factor.
IGFBPs -1 and -2 both contain an RGD peptide se- normal pregnancy. Although surprisingly little is known
with certainty about the details of decidual function (Tara-quence, which is associated with binding to the extracel-
lular matrix. Recently, IGFBP-1 has been shown to local- chand, 1986; Abrahamsohn and Zorn, 1993), one of the most
likely functions is to limit the scope of trophoblast inva-ize to the extracellular matrix by binding to a5b1-integrin
and to enhance the migration of CHO ®broblasts (Jones et sion, a role which must be balanced against the need to
support the respiratory needs of the conceptus. While im-al., 1993a) and human cytotrophoblasts (Irving and Lala,
1995) on a5b1-integrin-containing substrates. Notably, plantation is clearly important to life, the aggressiveness of
trophoblast invasion has been likened to a pseudomalig-a5b1-integrin is expressed by the rat uterine epithelium
(Nishida et al., 1991) and murine ectoplacental cone cells nancy (Kirby and Cowell, 1968) and can result in highly
metastatic choriocarcinomas (Strickland and Richards,(Sutherland et al., 1993), and antibodies against the b1-
subunit signi®cantly impair the ability of murine cyto- 1992). The IGF system is thought to be important in the
behavior of many malignancies (reviewed in LeRoith et al.,trophoblasts to spread over decidual cells (Yoshimura et
al., 1995). We suggest that IGFBP-1 may facilitate embry- 1995a), and the uterine pattern of IGFBP hybridization is
consistent with regulating trophoblast and decidual expo-onic invasion of the ULE and decidua through a direct
interaction with a5b1-integrin. The other major ligand sure to IGFs. As demonstrated in the ULE and periluminal
stroma, uterine IGFBP expression occurs in layers, and thisof a5b1-integrin is ®bronectin, and Damsky et al. (1994)
have shown that blocking ®bronectin binding accelerates is also true with respect to the decidua. With the exception
of blood vessels and a few IGFBP-3-expressing stromal cells,cytotrophoblast invasion in vitro. IGFBP-1 may therefore
act to promote cell motility by interfering with ®bronec- there is relatively little decidual IGFBP expression near the
embryo. However, at the margins of the decidualized endo-tin±integrin binding.
In contrast to IGFBP-1, we detect no transcription of metrium several IGFBPs are strongly expressed in a laminar
array, with IGFBP-4 straddling the decidual boundary dur-RGD-containing IGFBP-2 in the pregnant ULE. This is a
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ing early decidualization, considerable IGFBP-3 transcrip- proliferation of early postimplantation pregnancy. In con-
trast, IGFBP-2 is limited to the circular layer and reachestion on the nondecidualized side of the boundary, and simi-
lar, but more limited, nondecidual IGFBP-5 hybridization. its highest level late in gestation. The functional signi®-
cance of differential gene expression between the two myo-Taken together these observations suggest that a ``tug of
war'' involving the IGF system may take place between metrial layers is unclear, although this phenomenon is not
uncommon [e.g., TGF-b3 (Das et al., 1992) and tenascininvasive/mitogenic tissues and the relatively static nonde-
cidualized endometrium. (Julian et al., 1994)]. A third pattern of myometrial expres-
sion occurs with IGFBP-6 mRNA, which gradually in-
creases in both muscle layers until late in gestation, when
Uterine Circulatory System hybridization signals are very intense. The rat IGFBP-6 pro-
moter contains an estrogen receptor binding site (Zhu et al.,IGFBPs are thought to be crucial to the maintainence of
circulating IGF levels and to the delivery of IGFs to particu- 1993), and uterine IGF-I is known to be estrogen responsive
(Sahlin et al., 1994), so it is likely that IGF-I and IGFBP-6lar tissues (reviewed in Delafontaine, 1995). We detect
strong expression of two of the binding proteins, IGFBPs are coregulated by estrogen in the myometrium. Further,
the extremely high levels of IGFBP-6 transcription during-3 and -4, in decidual blood vessels. In the adult, IGFBP-3
is the major serum IGFBP and can signi®cantly extend the the placental period suggest that it may be the major modu-
lator of IGF activity in the uterine muscle.half-life of serum IGFs (Guler et al., 1989). While uterine
endothelial IGFBP-3 possibly contributes to the stability of In addition to the complicated changes in uteroplacental
IGFBP transcription described here, other groups have re-circulating IGFs, it may also act in an autocrine fashion by
binding to endothelial cell surfaces and modulating local ported pregnancy-associated IGFBP-speci®c proteases in
maternal serum (Davenport et al., 1990; Giudice et al.,IGF activity. During decidualization, maternal blood ves-
sels are transformed into sinusoids, as endothelial cells hy- 1990; Hossenlopp et al., 1990). Taken together, these results
suggest the importance of precise IGFBP regulation duringpertrophy and vessel walls become fenestrated. Hybridiza-
tion of IGFBP-3 to decidual endothelia is detected through- pregnancy. It remains unclear, however, whether the
IGFBPs act primarily as IGF enhancers or inhibitors, or pos-out the sinusoidal transformation, peaking as trophoblast
giant cells come into contact with maternal vessels. Like- sibly as IGF-independent factors during pregnancy. It is per-
haps most likely that the IGFBPs may do all of the abovewise, IGFBP-3 mRNA expression is associated with devel-
opment of blood vessels in the rat embryo and in several as a group, but that the individual IGFBPs have discrete,
tissue-speci®c functions. A more precise answer requirestumor types (J. Cerro, A. Grewal, and J. Pintar, unpublished
results), so it is likely that IGFBP-3 is involved in the remod- better in vivo models, such as mice incapable of producing
particular IGFBPs obtained through gene targeting (Pintareling of the decidual vasculature.
Although IGFBP-4 is generally an IGF inhibitor (Jones and et al., 1996).
Clemmons, 1995), its expression in the vasculature has been
associated with transport of IGFs across endothelia (Bar et
al., 1990). Interestingly, strong vascular IGFBP-4 expression ACKNOWLEDGMENTS
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